Soluble endoglin modulates aberrant cerebral vascular remodeling

Annals of Neurology

Volumn 66, Issue 1, 2009, Pages 19-27

  Chen, Yongmei ^a   Hao, Qi ^a   Kim, Helen ^a   Su, Hua ^a   Letarte, Michelle ^b   Karumanchi, S Ananth ^c   Lawton, Michael T ^a   Barbaro, Nicholas M ^a   Yang, Guo Yuan ^a   Young, William L ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; ENDOGLIN; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; SUPEROXIDE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ARTERIOVENOUS MALFORMATION; CAPILLARY DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DYSPLASIA; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPILEPSY; FEMALE; GENE TRANSFER; HUMAN; IMMUNOCYTOCHEMISTRY; MALE; MORBIDITY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; WESTERN BLOTTING; ZYMOGRAPHY;

ADULT; ALDEHYDES; ANIMALS; ANTIGENS, CD; ANTIGENS, CD31; CENTRAL NERVOUS SYSTEM VASCULAR MALFORMATIONS; CYSTEINE PROTEINASE INHIBITORS; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MALE; MALFORMATIONS OF CORTICAL DEVELOPMENT; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MIDDLE AGED; RECEPTORS, CELL SURFACE; STATISTICS, NONPARAMETRIC; SUPEROXIDES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 69249125704     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21710     Document Type: Article

References (39)

1. Arteriovenous Malformation Study Group. Arteriovenous malformations of the brain in adults. N Engl J Med 1999;340: 1812-1818.
2. Young WL. Intracranial arteriovenous malformations: pathophysiology and hemodynamics. In: Jafar JJ, Awad IA, Rosenwasser RH, eds. Vascular Malformations of the Central Nervous System. New York, NY: Lippincott Williams & Wilkins; 1999:95-126.
3. Kim H, Marchuk DA, Pawlikowska L, et al. Genetic considerations relevant to intracranial hemorrhage and brain arteriovenous malformations. Acta Neurochir Suppl 2008;105: 199-206.
4. Gougos A, Letarte M. Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line. J Immunol 1988;141:1925-1933.
5. Matsubara S, Bourdeau A, terBrugge KG, et al. Analysis of endoglin expression in normal brain tissue and in cerebral arteriovenous malformations. Stroke 2000;31:2653-2660.
6. Barbara NP, Wrana JL, Letarte M. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily. J Biol Chem 1999;274:584-594.
7. McAllister KA, Grogg KM, Johnson DW, et al. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 1994; 8:345-351.
8. Satomi J, Mount RJ, Toporsian M, et al. Cerebral vascular abnormalities in a murine model of hereditary hemorrhagic telangiectasia. Stroke 2003;34:783-789.
9. Venkatesha S, Toporsian M, Lam C, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006;12:642-649.
10. Toporsian M, Gros R, Kabir MG, et al. A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia. Circ Res 2005;96: 684-692.
11. Halim AX, Singh V, Johnston SC, et al. Characteristics of brain arteriovenous malformations with coexisting aneurysms: a comparison of two referral centers. Stroke 2002;33:675-679.
12. Hashimoto T, Wu Y, Lawton MT, et al. Co-expression of angiogenic factors in brain arteriovenous malformations. Neurosurgery 2005;56:1058-1065.
13. Hashimoto T, Lawton MT, Wen G, et al. Gene microarray analysis of human brain arteriovenous malformations. Neurosurgery 2004;54:410-423.
14. Hashimoto T, Emala CW, Joshi S, et al. Abnormal pattern of Tie-2 and vascular endothelial growth factor receptor expression in human cerebral arteriovenous malformations. Neurosurgery 2000;47:910-918.
15. Chen Y, Xu B, Arderiu G, et al. Retroviral delivery of homeobox d3 gene induces cerebral angiogenesis in mice. J Cereb Blood Flow Metab 2004;24:1280-1287.
16. Hao Q, Chen Y, Zhu Y, et al. Neutrophil depletion decreases VEGF-induced focal angiogenesis in the mature mouse brain. J Cereb Blood Flow Metab 2007;27:1853-1860.
17. Hao Q, Su H, Marchuk DA, et al. Increased tissue perfusion promotes capillary dysplasia in the ALK1-deficient mouse brain following VEGF stimulation. Am J Physiol Heart Circ Physiol 2008;295:H2250-H2256.
18. Calabro L, Fonsatti E, Bellomo G, et al. Differential levels of soluble endoglin (CD105) in myeloid malignancies. J Cell Physiol 2003;194:171-175.
19. Blann AD, Wang JM, Wilson PB, Kumar S. Serum levels of the TGF-beta receptor are increased in atherosclerosis. Atherosclerosis 1996;120:221-226.
20. Bourdeau A, Cymerman U, Paquet ME, et al. Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1. Am J Pathol 2000;156:911-923.
21. Velasco-Loyden G, Arribas J, Lopez-Casillas F. The shedding of betaglycan is regulated by pervanadate and mediated by membrane type matrix metalloprotease-1. J Biol Chem 2004;279: 7721-7733.
22. Hashimoto T, Matsumoto M, Li JF, et al. Suppression of MMP-9 by doxycycline in brain arteriovenous malformations. BMC Neurol 2005;5:1.
23. Chen Y, Pawlikowska L, Yao JS, et al. Interleukin-6 involvement in brain arteriovenous malformations. Ann Neurol 2006; 59:72-80.
24. Chen Y, Fan Y, Poon KY, et al. MMP-9 expression is associated with leukocytic but not endothelial markers in brain arteriovenous malformations. Front Biosci 2006;11:3121-3128.
25. Paquet ME, Pece-Barbara N, Vera S, et al. Analysis of several endoglin mutants reveals no endogenous mature or secreted protein capable of interfering with normal endoglin function. Hum Mol Genet 2001;10:1347-1357.
26. Pawlikowska L, Tran MN, Achrol AS, et al. Polymorphisms in genes involved in inflammatory and angiogenic pathways and the risk of hemorrhagic presentation of brain arteriovenous malformations. Stroke 2004;35:2294-2300.
27. Achrol AS, Pawlikowska L, McCulloch CE, et al. Tumor necrosis factor-alpha-238G>A promoter polymorphism is associated with increased risk of new hemorrhage in the natural course of patients with brain arteriovenous malformations. Stroke 2006;37:231-234.
28. Kim H, Hysi PG, Pawlikowska L, et al. Common variants in interleukin-1-beta gene are associated with intracranial hemorrhage and susceptibility to brain arteriovenous malformations. Cerebrovasc Dis. 2009;27:176-182.
29. Achrol AS, Pawlikowska L, McCulloch CE, et al. TNFa-238G>A promoter polymorphism is associated with increased risk of new hemorrhage in the natural course of patients with brain arteriovenous malformations [abstract]. Stroke 2006;37: 638-639.
30. Cudmore M, Ahmad S, Al-Ani B, et al. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation 2007;115:1789-1797.
31. Marchuk DA, Srinivasan S, Squire TL, Zawistowski JS. Vascular morphogenesis: tales of two syndromes. Hum Mol Genet 2003;12:R97-R112.
32. Letteboer TG, Mager JJ, Snijder RJ, et al. Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia. J Med Genet 2006;43:371-377.
33. Narumiya H, Zhang Y, Fernandez-Patron C, et al. Matrix metalloproteinase-2 is elevated in the plasma of women with preeclampsia. Hypertens Pregnancy 2001;20: 185-194.
34. Chung AW, Hsiang YN, Matzke LA, et al. Reduced expression of vascular endothelial growth factor paralleled with the increased angiostatin expression resulting from the upregulated activities of matrix metalloproteinase-2 and-9 in human type 2 diabetic arterial vasculature. Circ Res 2006;99:140-148.
35. Hashimoto T, Wen G, Lawton MT, et al. Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations. Stroke 2003;34: 925-931.
36. McCormick WF. Pathology of vascular malformations of the brain. In: Wilson CB, Stein BM, eds. Intracranial Arteriovenous Malformations. Baltimore, MD: Williams & Wilkins; 1984:44-63.
37. Attia W, Tada T, Hongo K, et al. Microvascular pathological features of immediate perinidal parenchyma in cerebral arteriovenous malformations: giant bed capillaries. J Neurosurg 2003; 98:823-827.
38. Sato S, Kodama N, Sasaki T, et al. Perinidal dilated capillary networks in cerebral arteriovenous malformations. Neurosurgery 2004;54:163-168.
39. Shenkar R, Elliott JP, Diener K, et al. Differential gene expression in human cerebrovascular malformations. Neurosurgery 2003;52:465-478.